Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CDRH Advisory Meeting Materials Archive
  • Print
  • Share
  • E-mail
-
New SearchBack To Search Results
Name of CommitteeNational Mammography Quality Assurance Advisory Committee
Date and TimeThe meeting was held on the following dates:
Sep 28, 2006 10:00 AM - 6:00 PM
Sep 29, 2006 8:00 AM - 1:00 PM
LocationAtrium Court Hotel, Remington 1 and 2
Three Research Ct.
Rockville , MD
Contact InformationNancy Wynne, Center for Devices and Radiological Health (HFZ-240), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850, 240-276-3284, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512397. Please call the Information Line for up-to-date information on this meeting.
AgendaThe committee will discuss: (1) Amendments to the current regulations, and (2) all guidance documents issued since the last meeting. The committee will also receive updates on recently approved alternative standards and the radiological health program. MQSA regulations and guidance documents are available to the public on the Internet at http://www.fda.gov/cdrh/mammography.
ProcedureInterested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before August 29, 2006. Oral presentations from the public will be scheduled between approximately 10:30 a.m. and 11:30 a.m. on September 28, 2006, and between approximately 8:30 a.m. and 9:30 a.m. on September 29, 2006. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before August 29, 2006.
 Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets.
ConductFDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/ for procedures on public conduct during advisory committee meetings.
Related Documents
Agenda:Agenda for September 28-29, 2006 Meeting PDF
Briefing:Briefing Information for September 28-29 MeetingPDF
Briefing:Additional Meeting Documents for September 28-29 MeetingText
Minutes:September 28, 2006 MeetingPDF
Minutes:September 29, 2006 MeetingPDF
Questions:September 28-29, 2006 MeetingPDF
Roster:Final Roster for September 28-29 MeetingPDF
Transcript:September 28, 2006 (Pages 1 - 100)PDF
Transcript:September 28, 2006 (Pages 101 - 200)PDF
Transcript:September 28, 2006 (Pages 201 - 262)PDF
Transcript:September 29, 2006 (Pages 1 - 100)PDF
Transcript:September 29, 2006 (Pages 101 - 208)PDF
Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).
-
-